Stockreport

BELLUS Health Announces Completion of Enrollment in Phase 2 RELIEF Trial of BLU-5937 for the Treatment of Refractory Chronic Cough

BELLUS Health Inc. - Common Shares  (BLU) 
Last bellus health inc. - common shares earnings: 11/14 07:00 am Check Earnings Report
PDF - On track to report topline data from the RELIEF trial in mid-2020 - LAVAL, Quebec--(BUSINESS WIRE)--BELLUS Health Inc. (Nasdaq:BLU; TSX:BLU) (the “Company” or “BELL [Read more]